From hardened software to scientific productivity, the NCBCs have changed the landscape for biomedical computing. What will happen when their funding expires?
Decades of steady progress in pharmacogenetics have unearthed hundreds of associations between genes and drug response. But the field has to solve some theoretical and practical issues before it can deliver on the promise of personalized drug therapy.
How researchers are combining disparate data types and simulating systems that contain many different moving parts
Computational modeling can help fill gaps in how we develop and review new drugs and devices
Modelers should take the lead.
How Simbios' state-of-the-art software tools are contributing to high-impact biomedical research
Supercomputers open up new horizons, offering the possibility of discovering new ways to understand life’s complexity